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Reducing cation-anion difference of diets (DCAD) fed just before parturition can prevent milk fever.
However this dietary regimen does not entirely eliminate hypocalcemia. Milk fever can also be pre-
vented by exogenous administration of the calcium regulating hormone 1,25-dihydroxyvitamin D.
Unfortunately 1,25-dihydroxyvitamin D treatment remains expensive and the pre-partal diets used
in most trials would be classified today as high in cations. Solanum glaucophyllum (Sg) is a plant that
contains high levels of a glycoside form of 1,25-dihydroxyvitamin D. S. Glaucophyllum is widely
distributed in the province of Buenos Aires in Argentina and in Brazil and causes the development
of a calcinotic disease in cattle called "Enteque Seco". In order to become active the glycoside must
be cleaved to liberate the 1,25(OH)2D3. Rumen microbes are very efficient at this process. Could ad-
ministration of Sg leaves to cows that were already being fed a low DCAD pre-partum diet further
improve calcium status at calving? Nine multiparous Jersey cows were fed a low DCAD diet prior to
calving. Urine pH of cows was maintained below 7.0 in all cows the week prior to parturition. Five
cows were daily given 2 or 3 g Sg leaves in gelatin boluses beginning 6 days (on average) before calv-
ing and continuing for the first 14 days of lactation. None of the four cows fed the low DCAD diet
only developed milk fever. Their blood calcium concentration was 7.6, 7.0 and 8.0 mg/dl the day of
calving and d 1 and 2 after calving respectively. Cows receiving Sg in addition to low DCAD diet
had significantly higher blood calcium concentration during the periparturient period with blood cal-
cium concentrations of 7.8, 8.8 and 9.3 mg/dl the day of calving and d 1 and 2 after calving respec-
tively. Defining subclinical hypocalcemia as blood calcium <7.5 mg/dl, control cows suffered an av-
erage of 3 days of subclinical hypocalcemia and the Sg treated cows suffered 0.8 d of subclinical
hypocalcemia the first 2 wk of lactation. Thus, Sg treatment improved calcium status in animals that
were also being fed a low DCAD diet. Unfortunately, all cows receiving Sg suffered 1-2 days of
hypocalcemia (1 cow developed milk fever) between 6 and 8 days after Sg treatment was ended.
Mean blood calcium on d 22 of lactation of Sg cows was 6.9 mg/dl compared with 9.2 mg/dl in un-
treated cows. It appears that Sg treatment supplanted the cow's own calcium homeostasis mecha-
nisms so that abrupt withdrawal of treatment left the cows temporarily unable to control blood cal-
cium concentration. Additional experiments were conducted using a phased withdraw approach.
Three cows were treated with Sg from 5 days prepartum to 7 postpartum (2 g Sg/d) from day 8-14
postpartum (1 g Sg/d) and day 15-21 postpartum (0.5 g Sg/d). The phased withdrawal approach re-
sulted in normal calcium concentration for up to 2 weeks following cessation of Sg. These data sug-
gest that Sg can be used successfully in the prevention of hypocalcemia and that a phased withdrawal
approach to removing the exogenous source of 1,25-(OH)2D3 was successful in avoiding the
hypocalcemic side effects associated with abrupt withdrawal.
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